# BioPharma Credit PLC USD (BPCP)

**Source:** https://fundology.uk/fund/bpcp · ISIN GB00BDGKMY29 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 30/09/2026, BPCP (BioPharma Credit PLC USD, ISIN GB00BDGKMY29) closed at £0.735 on the London Stock Exchange. Over the five years to 30/09/2026 its price changed by +1.2% (income paid out is not included), or −19.9% after UK CPIH inflation.

## Summary

BioPharma Credit PLC USD is an investment trust. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Latest close: **£0.735** (30/09/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | BPCP |
| ISIN | GB00BDGKMY29 |
| Category | Corporate & other bonds |
| Type | Investment trust |
| Domicile | United Kingdom |

## Past returns (periods to 30/09/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +9.70% | +6.72% | price only |
| 3 years | +5.76% | -3.98% | price only |
| 5 years | +1.24% | -19.94% | price only |

Returns: Fundology, from recorded daily closes. Inflation: ONS CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of BioPharma Credit PLC USD in pounds (price only, income paid out not included): 2022 +6.6%, 2023 −14.6%, 2024 +3.8%, 2025 −0.9%; 2026 to 30/09/2026 +7.8%. Returns of BioPharma Credit PLC USD in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +8.2%; to 30/09/2025: +0.7%; to 30/09/2024: −1.6%; to 30/09/2023: −18.0%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | +6.6% | -2.4% | Price |
| 2023 | -14.6% | -18.0% | Price |
| 2024 | +3.8% | +0.2% | Price |
| 2025 | -0.9% | -4.3% | Price |
| 2026 to 30/09/2026 | +7.8% | +4.8% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 10.88% | -4.85% |
| 3 years | 11.24% | -13.42% |
| 5 years | 11.32% | -25.78% |

## Largest fall

Volatility of BioPharma Credit PLC USD in pounds, annualised from weekly returns to 30/09/2026: 10.9% over 1 year, 11.2% over 3 years, 11.3% over 5 years. Largest fall in the price of BioPharma Credit PLC USD since October 2021, in pounds: −25.8% from 23/09/2022 to 11/04/2025. The lowest 12-month return of BioPharma Credit PLC USD in pounds (price only, income paid out not included) since October 2021 was −22.8% (12 months to 22/09/2023); the highest was +19.7% (12 months to 04/11/2022). On 30/09/2026 the price of BioPharma Credit PLC USD was 15.4% below its highest weekly close since October 2021 (23/09/2022), in pounds.

## Charges & eligibility

- ISA eligible: yes
- SIPP eligible: yes

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.